Pubblicazioni primo autore Lorenza Rimassa

Lorenza Rimassa et. al, Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition

Marco Amadio 2019-03-07T09:41:15+00:00